Poseida Therapeutics, Inc. (PSTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.7100 |
| Open | 2.7400 |
| Bid | 2.7100 x 100 |
| Ask | 2.7600 x 400 |
| Day's range | 2.6250 - 2.7850 |
| 52-week range | 1.8300 - 4.2700 |
| Volume | |
| Avg. volume | 429,630 |
| Market cap | 266.147M |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Poseida Therapeutics Second Quarter 2024 Earnings: Beats Expectations
Poseida Therapeutics ( NASDAQ:PSTX ) Second Quarter 2024 Results Key Financial Results Revenue: US$26.0m (up 30% from...
- Zacks
Poseida Therapeutics, Inc. (PSTX) Reports Q2 Loss, Tops Revenue Estimates
Poseida Therapeutics (PSTX) delivered earnings and revenue surprises of 25.58% and 88.90%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) institutional investors lost 22% over the past week but have profited from longer-term gains
Key Insights Institutions' substantial holdings in Poseida Therapeutics implies that they have significant influence...
© 2024 Yahoo. All rights reserved.